According to data released by the World Health Organization, an estimated 325 million people worldwide are living with ...

In the past two decades, there have been major developments in the treatment of chronic hepatitis B. Peginterferon can be given conveniently with weekly dosing, and its effect on hepatitis B e ...

Despite numerous treatment advances, chronic hepatitis B virus (HBV) infection remains ... Meanwhile, the predominant absence of symptoms both prevents early treatment and increases the ...

People with chronic hepatitis B – especially if they have advanced fibrosis or cirrhosis, have a family history of liver cancer or are of Asian or African origin – should also be screened every six ...

Today, nearly 300 million people worldwide live with chronic hepatitis B (CHB), the complications of which cause approximately one death every 30 seconds 1. In addition to living with a ...

However, whether these phenomena hold true for chronic hepatitis B virus (HBV) infection remains largely unknown. The present study therefore aimed to investigate the association of chronic HBV ...

More information: Jinlin Hou et al, Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B, New England Journal of Medicine (2024). DOI: 10.1056/NEJMoa2405485 ...